Medifast (NYSE:MED) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $(0.22) by 200 percent. This is a 76.09 percent decrease over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $105.60 million which beat the analyst consensus estimate of $96.10 million by 9.89 percent. This is a 37.35 percent decrease over sales of $168.56 million the same period last year.